Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.

Article  PubMed  Google Scholar 

Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26(2suppl):25–32.

Article  PubMed  Google Scholar 

Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular complications of type 2 diabetes Mellitus. Curr Vasc Pharmacol. 2020;18(2):117–24.

Article  PubMed  CAS  Google Scholar 

Cho Y, Park HS, Huh BW, Seo SH, Seo DH, Ahn SH, et al. Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus. Diabetes Metab. 2022;48(6):101389.

Article  PubMed  CAS  Google Scholar 

Pfeiffer AF, Klein HH. The treatment of type 2 diabetes. Dtsch Arztebl Int. 2014;111(5):69–81. quiz 82.

PubMed  PubMed Central  Google Scholar 

Musazadeh V, Roshanravan N, Mohammadizadeh M, Kavyani Z, Dehghan P, Mosharkesh E. Curcumin as a novel approach in improving lipid profile: an umbrella meta-analysis. Nutr Metab Cardiovasc Dis. 2022;32(11):2493–504.

Article  PubMed  CAS  Google Scholar 

Zarezadeh M, Musazadeh V, Faghfouri AH, Sarmadi B, Jamilian P, Jamilian P, et al. Probiotic therapy, a novel and efficient adjuvant approach to improve glycemic status: an umbrella meta-analysis. Pharmacol Res. 2022;183:106397.

Article  PubMed  CAS  Google Scholar 

Abbasi S, Mashatan N, Farmani E, Khodashenas M, Musazadeh V, Ahrabi SS, et al. The effects of purslane (Portulaca oleracea) on glycemic indices: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2023;37(12):5529–40.

Article  PubMed  CAS  Google Scholar 

Musazadeh V, Kavyani Z, Mirhosseini N, Dehghan P, Vajdi M. Effect of vitamin D supplementation on type 2 diabetes biomarkers: an umbrella of interventional meta-analyses. Diabetol Metab Syndr. 2023;15(1):76.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zarezadeh M, Musazadeh V, Foroumandi E, Keramati M, Ostadrahimi A, Mekary RA. The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes or with polycystic ovary syndrome: an umbrella meta-analysis on interventional meta-analyses. Diabetol Metab Syndr. 2023;15(1):127.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Moridpour AH, Kavyani Z, Khosravi S, Farmani E, Daneshvar M, Musazadeh V, et al. The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes mellitus: an updated systematic review and dose-response meta-analysis of randomized controlled trials. Phytother Res. 2024;38(1):117–30.

Article  PubMed  CAS  Google Scholar 

Hall KD, Bemis T, Brychta R, Chen KY, Courville A, Crayner EJ, et al. Calorie for calorie, Dietary Fat Restriction results in more body Fat loss than Carbohydrate Restriction in people with obesity. Cell Metab. 2015;22(3):427–36.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Castro-Barquero S, Ruiz-León AM, Sierra-Pérez M, Estruch R, Casas R. Dietary strategies for metabolic syndrome: a Comprehensive Review. Nutrients. 2020;12(10).

Zhu S, Surampudi P, Rosharavan B, Chondronikola M. Intermittent fasting as a nutrition approach against obesity and metabolic disease. Curr Opin Clin Nutr Metab Care. 2020;23(6):387–94.

Article  PubMed  PubMed Central  Google Scholar 

Wang X, Li Q, Liu Y, Jiang H, Chen W. Intermittent fasting versus continuous energy-restricted diet for patients with type 2 diabetes mellitus and metabolic syndrome for glycemic control: a systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2021 (1872–8227 (Electronic)).

Teong XT, Heilbronn LK. Evidence gaps and potential roles of intermittent fasting in the prevention of chronic diseases. Exp Gerontol. 2021;153:111506.

Article  PubMed  Google Scholar 

Boccardi V, Pigliautile M, Guazzarini AG, Mecocci P. The Potential of Fasting-Mimicking Diet as a Preventive and Curative Strategy for Alzheimer’s Disease. Biomolecules. 2023;13(7).

Mayra ST, Chondropoulos K, De Leon A, Kravat N, Johnston CS. The feasibility and preliminary efficacy of early time-restricted eating on diet quality in college students: a randomized study. Obes Res Clin Pract. 2022 Sep-Oct;16(5):413–20.

Kord-Varkaneh H, Salehi-Sahlabadi A, Tinsley GM, Santos HO, Hekmatdoost A. Effects of time-restricted feeding (16/8) combined with a low-sugar diet on the management of non-alcoholic fatty liver disease: a randomized controlled trial. Nutrition. 2023;105:111847.

Article  PubMed  CAS  Google Scholar 

Yang X, Zhou J, Shao H, Huang B, Kang X, Wu R, et al. Effect of an intermittent calorie-restricted Diet on type 2 diabetes remission: a Randomized Controlled Trial. J Clin Endocrinol Metab. 2022;108(6):1945–7197.

Google Scholar 

Catenacci VA, Pan Z, Ostendorf D, Brannon S, Gozansky WS, Mattson MP, et al. A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity. Obes (Silver Spring). 2016;24(9):1874–83.

Article  CAS  Google Scholar 

Trepanowski JF, Kroeger CM, Barnosky A, Klempel MC, Bhutani S, Hoddy KK, et al. Effect of alternate-day fasting on weight loss, Weight Maintenance, and Cardioprotection among metabolically healthy obese adults: a Randomized Clinical Trial. JAMA Intern Med. 2017;177(7):930–38.

Article  PubMed  PubMed Central  Google Scholar 

Headland ML, Clifton PM, Keogh JB. Effect of intermittent compared to continuous energy restriction on weight loss and weight maintenance after 12 months in healthy overweight or obese adults. Int J Obes (Lond). 2019;43(10):2028–36.

Article  PubMed  CAS  Google Scholar 

Fanti M, Mishra A, Longo VD, Brandhorst S, Time-Restricted, Eating. Intermittent fasting, and fasting-mimicking diets in weight loss. Curr Obes Rep. 2021;10(2):70–80.

Article  PubMed  Google Scholar 

Li C, Sadraie B, Steckhan N, Kessler C, Stange R, Jeitler M, et al. Effects of a one-week fasting therapy in patients with Type-2 diabetes Mellitus and metabolic syndrome - A Randomized Controlled Explorative Study. Exp Clin Endocrinol Diabetes. 2017;125(9):618–24.

Article  PubMed  CAS  Google Scholar 

Ezzati A, Rosenkranz SK, Phelan J, Logan C. The effects of Isocaloric Intermittent Fasting vs Daily Caloric Restriction on Weight loss and metabolic risk factors for noncommunicable chronic diseases: a systematic review of Randomized controlled or comparative trials. J Acad Nutr Diet. 2023;123(2):318–e291.

Article  PubMed  Google Scholar 

de Cabo R, Mattson MP. Effects of Intermittent Fasting on Health, Aging, and Disease. N Engl J Med. 2019;381(26):2541–51.

Article  PubMed  Google Scholar 

Vasim I, Majeed CN, DeBoer MD. Intermittent Fasting Metabolic Health Nutrients. 2022;14(3).

Xiaoyu W, Yuxin X, Li L. The effects of different intermittent fasting regimens in people with type 2 diabetes: a network meta-analysis. Front Nutr. 2024 (2296-861X (Print)).

Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017 (1756–833 (Electronic)).

Page MA-O, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 (1756–833 (Electronic)).

Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968;70(4):213–20.

Article  PubMed  CAS  Google Scholar 

Li M, Gao Q, Yu T. Kappa statistic considerations in evaluating inter-rater reliability between two raters: which, when and context matters. BMC Cancer. 2023;23(1):799.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.

Article  PubMed  Google Scholar 

Carter S, Clifton PM, Keogh JB. The effects of intermittent compared to continuous energy restriction on glycaemic control in type 2 diabetes; a pragmatic pilot trial. Diabetes Res Clin Pract. 2016;122(Electronic):1872–8227.

Google Scholar 

Carter S, Clifton PM, Keogh JB. Effect of intermittent compared with continuous energy restricted Diet on Glycemic Control in patients with type 2 diabetes: a Randomized Noninferiority Trial. JAMA Netw Open. 2018 (2574–3805 (Electronic)).

Corley BA-O, Carroll RW, Hall RM, Weatherall M, Parry-Strong A, Krebs JD. Intermittent fasting in type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial. Diabet Med. 2018;35(5):1464–5491.

Article  Google Scholar 

Carter S, Clifton PM, Keogh JB. The effect of intermittent compared with continuous energy restriction on glycaemic control in patients with type 2 diabetes: 24-month follow-up of a randomised noninferiority trial. Diabetes Res Clin Pract. 2019;151(Electronic):1872–8227.

Google Scholar 

McDiarmid SA-O, Harvie MA-O, Johnson RA-OX, Vyas AA-O, Aglan A, Moran JA-OX et al. Manchester intermittent versus daily Diet App Study (MIDDAS): a pilot randomized controlled trial in patients with type 2 diabetes. Diabetes Obes Metab. 2021 (1463 – 1326 (Electronic)).

Pavlou V, Cienfuegos S, Lin S, Ezpeleta M, Ready K, Corapi S et al. Effect of time-restricted eating on weight loss in adults with type 2 diabetes: a Randomized Clinical Trial. AMA Netw Open. 2023 (2574–3805 (Electronic)).

Karatoprak C, Yolbas S, Fau - Cakirca M, Cakirca M, Fau - Cinar A, Cinar A, Fau - Zorlu M, Zorlu M, Fau - Kiskac M, Kiskac M, Fau - Cikrikcioglu MA, et al. The effects of long term fasting in Ramadan on glucose regulation in type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci. 2013;17(18):1128–3602.

Google Scholar 

Tang FA-O, Lin XA-O. Effects of Fasting-Mimicking Diet and specific meal replacement Foods on blood glucose control in patients with type 2 diabetes: a Randomized Controlled Trial. Oxid Med Cell L